跳至主要内容
临床试验/NCT04000087
NCT04000087已完成不适用

Electrocardiogram Artificial Intelligence-Guided Screening for Low Ejection Fraction (EAGLE)

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 358 人开始时间: 2019年6月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
358
试验地点
2
主要终点
New Diagnosis of Low Ejection Fraction (defined as ejection fraction ≤50%)

研究概览

简要总结

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of left ventricular systolic dysfunction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary care clinicians who are part of a participating care team that care for adult patients and have the ability to order ECG and TTE (this includes physicians, nurse practitioners, and physician assistants).

排除标准

  • Primary care clinicians working in pediatrics, acute care, nursing homes, and resident care teams.

结局指标

主要结局

New Diagnosis of Low Ejection Fraction (defined as ejection fraction ≤50%)

时间窗: Within 90 days

Ejection fraction obtained by echocardiography.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiaoxi Yao

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验